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ABSTRACT

Ogden, Dorothy J. M.S., Department of Chemistry, Wright State University, 2011.
Modifiable Hyperbranched Polyester Drug Delivery Systems.

This work encompassed synthesis and characterization of biocompatible hyperbranched
polyester drug delivery systems prepared with fumaric acid, glycerol and polyethylene glycol.
The polymers were manufactured in the melt utilizing A2 + CB2 polymerization. The ratio of
A2:CB2 was modified and excess B was added to end-cap the polymers to avoid cross-linking.
Fumaric acid was selected as the A2 monomer because the double bond provided a site for
polymer backbone modification or covalent attachment of active pharmaceutical ingredients.
Acetaminophen and Ondansetron Hydrochloride were added to evaluate feasibility of using the
polyesters as drug delivery systems. The weight average molecular weight of the A2 + CB2
polymer systems with the end-capping agent ranged from 5100 to 8500 Da with PDI values
between 1.3 and 1.7. The polymers containing Acetaminophen appeared to degrade while the
polymers with Ondansetron were determined to be immediate-release dosage forms.
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I.

INTRODUCTION

The main objective of this project was to study modifiable A2 + CB2 hyperbranched polyester
polymers. Naturally occurring polymers are prevalent throughout the world and include cotton, latex,
starch, proteins, DNA and cellulose. Some common synthetic polymers include Bakelite, Teflon, Nylon
and Kevlar. Polymers are large molecular weight compounds composed of repeat unit(s) called
monomers. A polymer can be composed of a single repeating monomer (homopolymer) or multiple
repeating monomers (copolymer). For instance, natural rubber is a homopolymer containing repeat
isoprene units. Just to clarify, monomers become the repeat units; poly(isoprene) is polymerized
isoprene.
Figure 1: Natural rubber homopolymer.
*
*
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Copovidone is a copolymer used in the pharmaceutical industry for controlled drug release. It is
prepared from 1‐vinyl‐2‐pyrrolidone and vinyl acetate monomers.1
Figure 2: Copovidone copolymer.
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Hyperbranched polymers are one of eight basic types of branched polymers. A perfectly
branched or 100% branched polymer is a dendrimer. Dendrimers are perfectly symmetrical and
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spherical with functional groups on the surface and/or inside the sphere. This makes dendrimers ideal
for drug delivery, along with many other uses, since they can be created to be water soluble and also to
contain binding sites for an active pharmaceutical ingredient (API). Variations of the dendrimer are
linear‐dendritic hybrids, dendronized polymers, dendrimer‐like star macromolecules (DendriMacro),
hyperbranched polymers, multiarm star polymers, hyperbranched polymer‐like star macromolecules
(HyperMacro) and hyperbranched polymer‐grafted linear macromolecules.2
Figure 3: Branched polymers (adapted from Gao et al.).2
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Hyperbranched polymers have become increasingly popular over the last twenty to thirty years
due to their inherent physical properties. These properties include good solubility, low solution
viscosity, thermal stability and a multitude of end groups.3 In the 1980s, Kim and Webster used the
terminology hyperbranched polymers to describe macromolecules with random branch‐on‐branch
configurations.4 Such macromolecules contain structural irregularities and are composed of linear,
dendritic and terminal repeat units. While dendrimers are typically synthesized using tedious multistep
2

methods, hyperbranched polymers are often produced via a one‐pot synthesis which is conducive to
large scale manufacturing.
Hyperbranched polymers can be prepared via numerous methods. These include, but are not
limited to, condensation, ring‐opening multibranching (ROMBP), proton‐transfer, atom transfer radical
(ATRP) and reversible addition‐fragmentation chain transfer (RAFT).5,6 Condensation polymerization is a
step‐growth process in which monomers are joined one at a time to form dimers, trimers, tetramers,
pentamers, etc. These small units then join to form larger ones and eventually become a polymer.
Typically, each monomer in condensation polymerization has at least two functional groups and as the
functional groups interact, a small molecule such as water is released. For instance an acid group on 3,5‐
dihydroxy‐benzoic acid can react with an alcohol on another molecule of 3,5‐dihydroxybenzoic acid to
form an ester and water. This undergoes subsequent condensations to form a hyperbranched
polyester.7
Scheme 1: Polycondensation to form polyester.
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ROMBP is a chain‐growth process which typically involves initiation, ring opening, propagation
and termination. In chain‐growth polymerization, the molecule grows link by link to form a polymer. Liu
et al. developed a procedure for preparing 4‐(2‐hydroxyethyl)‐epsilon‐caprolactone which employs a
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primary alcohol to initiate ring opening via the carbonyl group. Primary alcohols on the resulting dimer
open additional rings to obtain a trimer, tetramer, etc. until a polymer is formed.8
Scheme 2: Ring‐opening multibranching polymerization (adapted from Liu et al.).8
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Proton transfer polymerization is another means for preparing hyperbranched polymers. It is a
chain‐growth process that involves deprotonation, nucleophilic attack and rapid proton exchange. This
polymerization is similar to ROMBP and was reported by Chang and Fréchet in 1999.9
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Scheme 3: Proton‐transfer polymerization (adapted from Chang et al.)9
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Atom transfer radical polymerization (ATRP) is a chain growth process and was reported by
Gaynor et al. in 1996.10 The one‐pot synthesis involves using p‐(chloromethyl)styrene as both the
initiator and the monomer. The process occurs by homolytical cleavage of the chlorine on the styrene
by Cu(I) to form Cu(II)Cl and a radical. The radical attacks the double bond on another styrene molecule
to form a polymer with pendant groups. The pendant groups can also react to form a hyperbranched
molecule.

5

Scheme 4: ATRP synthesis (adapted from Gaynor et al.).10
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RAFT or reversible addition‐fragmentation chain transfer polymerization is another chain growth
process. In this mode, polymerization is reversible and occurs via chain transfer. Moad et al. described
a process in which carbon sulfur bonds were broken and monomer was inserted.11 The resulting
molecule serves as the RAFT agent as presented in Scheme 5. Polymerization proceeds by chain
transfer, reinitiation, chain equilibration and then termination.
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Scheme 5: RAFT agent synthesis (adapted from Moad et al.).11
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An overview of several modes for preparing hyperbranched polymers has been presented.
Focus will now be directed to polycondensation polymerization since it is one of the simplest and
straightforward methods for preparing polymers.
One of the most famous works regarding polycondensation theory is that of Flory in which he
described synthesis of branched polymers.12 He theorized that a condensation of two monomers, one
with a single A functional group and one with two or more B functional groups (ABx), could be
performed to create a highly branched polymer without gelation. Gelation occurs when polymer chains
cross‐link by forming intermolecular covalent or ionic bonds. This typically results in a polymer with
undesirable physical properties such as low solubility and limited to no end‐group functionality.
According to Flory, the probability that an A functional group has been incorporated in a branching unit
is α=ρA and the probability that a B group has been reacted is α=ρB. By definition, the number of A
groups incorporated must equal the number of B groups incorporated, so in an ABf system, ρB(f – 1)=ρA.
Furthermore, α=ρA/(f – 1) or α=ρ/(f – 1). Thus, the probability that a functional group is incorporated
into a branch unit will always be less than ρ/(f – 1) for ABx polymers. This equates to the possibility of
non‐cross‐linked polymers that can be made in a one‐step polycondensation reaction. A multitude of
such ABx hyperbranched polymers were developed throughout the late 1980s and 1990s. These include,
but are not limited to, polyamides, polyphenylenes and polyethers.
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Scheme 6: Polycondensation to form polyether.13
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However, the ABn systems do not come without significant drawbacks: cyclization can occur and
the monomers can be too reactive, expensive or not readily available.3,14 In 1999, Jikei et al. reported
the synthesis of a hyperbranched polyamide using an A2 + B3 system.15

Emrick et al. followed with A2 +

B3 polyethers that contained highly functional end groups.16 The advantages of the A2 + B3 systems are
that the monomers are readily available and soluble and three dimensional hyperbranched polymers
may be attained as long as gelation is controlled.15 Flory described A2 + B3 systems in the early 1940s
when he discussed gelation and the degree of polymerization.17 Flory theorized there was a critical
condition in which a polymer would cross‐link and presented calculations to predict the critical points.
Stockmayer furthered Flory’s work and compared gelation to the condensation of a saturated vapor.18
Both Flory and Stockmayer stated that the critical point of gelation, ρc, is related to the number of
functional groups on the monomer as given in Equation 1.
1
1
Equation 1
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When two monomers are present, the critical point of gelation becomes inversely proportional to
the functionality of both monomers as detailed in Equation 2. Where χa = molar functionality of the A
monomer and χb = molar functionality of the B monomer.
1
1

1

/

Equation 2
Therefore, for A2 + B3 polymerization with the monomers at a molar ratio of 1:1,
0.71. When the molar ratio of A:B is 1:1.5, ρc = 0.85.

Obviously, gelation is a concern in the A2 + B3 system where it is not an issue at all in the ABn
reactions. Fortunately, the gelation problem can be dealt with by three major means: allow cyclization
to occur in an opportunistic manner, stop the reaction before the reaction reaches the critical
conversion point or allow the polymerization to reach a higher conversion rate by adding additional
species such as excess A or B or another functional group such as C. Lin and Long overcame gelation
when they prepared hyperbranched poly(aryl ester)s by making dilute solutions of each monomer and
then slowly adding the A2 monomer solution to the B3 monomer solution.19 Jikei et al. avoided gelation
while forming aromatic polyamides by controlling the ratio of A to B functional groups.15 Stumbé and
Bruchmann avoided gelation by closely monitoring and controlling the rate of reaction in the synthesis
of hyperbranched polyesters.20 If gelation is restricted, A2 + B3 polymerization systems offer an easy
and cost‐effective means for preparing hyperbranched polymers.
Within the last couple of years, A2 + CB2 polymerization has gained some attention. In this
system, the C functional group has a different reactivity than the B2 functional groups. In 2009, Zhou et
al. presented a model for A2 + CB2 systems in which C was significantly more reactive than B2.21 They
proposed that during early stages of synthesis, the C would react rapidly with one of the A groups which
would then leave the second A group to react with the two B groups. They also speculated that the AB2
9

intermediate could react with the CB2 monomer and result in A being attached to four B groups. This
entity could serve as a “core” for polymerization which could potentially lead to a hyperbranched
polymer with a very narrow molecular weight distribution. Wang et al. prepared hyperbranched
polysiloxysilanes using A2 + CB2 systems.22 They described the B4 core and also varied monomer ratios to
control physical properties (i.e. molecular weight, viscosity) of the polymer without gelation occurring.
Scheme 7: A2 + CB2 synthesis of polysiloxysilanes (adapted from Wang et al.).22
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Another important aspect of hyperbranched polymers is the degree of branching (DB). DB
corresponds closely with the physical properties of the polymer such as chain entanglement, glass‐
transition temperature, mechanical strength, etc. of the polymer.2 While dendrimers are perfectly
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branched (100%), hyperbranched polymers are not. In 1991, Hawker et al. defined the degree of
branching for AB2 systems as being equal to the sum of dendritic (D) and terminal (T) units divided by
the total number of units (dendritic, terminal and linear (L)): DB = (D+T)/(D+T+L).23 For AB2 polymers
with high molecular weights, the number of terminal units is practically equal to the number of dendritic
units. Therefore, the maximum degree of branching is equal to 2D/(2D+L), which correlates to 50%
branching for AB2 systems. For A2 + B3 polymerization, the degree of branching becomes that as
described in Equation 3.24
2

2

2

2
Equation 3

Here, [b3] is equal to the dendritic B groups and [Bb2] is equal to the linear B groups. DB can be
controlled for A2 + B3 systems by modifying the feed ratio or by the order of addition of the monomers.3
When the concentration of A2 increases, the DB increases. This results in a highly branched polymer and
a DB of 0.93 (i.e. 93% branching), can be attained.24 A polymer with this high degree of branching will
tend to have physical properties similar to a dendrimer but without the tedious synthesis steps.
As previously mentioned, hyperbranched polymers have some good physical properties:
solubility, viscosity and stability. The abundance of highly functionalized end groups also makes them
good candidates for drug delivery. Polymers have been in pharmaceuticals for decades and there are
numerous ones that have been deemed GRAS (Generally Recognized As Safe) by the Food & Drug
Administration (FDA). GRAS ingredients do not require extensive toxicological evaluation so they are
the ingredients of choice if given options. Polymethacrylates are GRAS and are used in enteric coatings
of solid oral dose tablets to control release in the gastrointestinal tract.1 Ethylcellulose (see Figure 4)
has many uses in the pharmaceutical industry but is most commonly used for extended release of oral
11

drugs. Polyethylene glycol (PEG) is typically found as a suspending agent, solubility enhancer or film
coating. Poloxamer is a GRAS triblock copolymer that is employed as a surfactant, emulsifier, solubilizer
and stabilizer. These are just four examples of polymers used in pharmaceuticals. However, it should
be noted that none of these examples include covalent or ionic bonding of the drug to the polymer to
control drug delivery. The polymers merely enhance the performance of the formulations.
Figure 4: GRAS polymers.
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Hyperbranched polymers, along with dendrimers, offer functional terminal end groups, an inner
core and linear as well as branched repeat units connecting the core to the end groups. 25 This enables a
drug to react with an end group, interact with the core such as in the case of a micelle or network with
the linear repeat units (Figure 5). These characteristics are ideal for proteins, gene therapy drugs and
anti‐cancer drugs because the drug can be imbedded or attached in the polymer and then transported
to the desired location in the body. This has become a widely studied area of polymer chemistry during
the last decade.
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Figure 5: Micelle‐like polymer (adapted from Gao et al.).2

In 2005, Dailey et al. presented applications of biodegradable poly (vinyl alcohol) and poly (lactic‐
co‐glycolic acid) branched polyesters in drug delivery.26 They prepared neutral, negatively charged and
positively charged polymers and then evaluated them for delivery of different drugs. The neutrally
charged species (Figure 6) appeared to be promising for drug delivery of three proteins. The negatively
charged polymers (Figure 7) seemed to be suitable for delivery of tetanus toxoid vaccines. The
positively charged macromolecules (Figure 8) were good candidates for DNA vaccines and peptides and
proteins. The positively charged species also seemed good candidates for use in nebulized suspensions
to be used for pulmonary drug delivery.
Figure 6: Neutral polymer.
*
*

z
x
O

y
OH

O

O

O

O

O
O

OH

O

O
m

n
O

13

Figure 7: Negatively charged polymer.
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Figure 8: Positively charged polymer.
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Pang et al. examined hyperbranched polymers containing polyethylene glycol and glycidyl
methacrylate.27 They coupled the polymer to methotrexate (Figure 9) and showed in vitro that the drug
delivery system was pharmacologically active. Ye et al. developed hyperbranched polyglycerols for
cisplatin drug delivery.28 They modified commercially available polyglycerols to change the carboxylic
acid density of the functional groups. The modified polymers were bound to cisplatin (Figure 10) and
demonstrated controlled release and in vitro activity.
Figure 9: Methotrexate.
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Figure 10: Cisplatin.
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One additional example of hyperbranched polymers in drug delivery is that recently published
by Chen et al. in which they used a negatively charged polysulfonamine.29 The polysulfonamine was
used to deliver doxorubicin (Figure 11) to human epidermoid tumor cells. Release of the drug was
controlled by pH and had a low cytotoxicity in normal cells.
Figure 11: Doxorubicin.
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The purpose of this work is to further the research of biocompatible hyperbranched polyesters
prepared by Werry in 2007.30 Werry synthesized hyperbranched polymers via the A2 + B3
polycondensation of fumaric acid (A2) and glycerol (B3). Werry experienced gelation issues during his
research and examined the effect that temperature and the molar ratio of A2:B3 had on cross‐linking. He
found that a lower temperature caused the reaction to proceed at a slower rate, which enabled the
reaction to be terminated before cross‐linking occurred. Werry observed that gelation was delayed as
the molar ratio of A2:B3 was decreased (i.e. when the glycerol concentration was increased while
maintaining the fumaric acid concentration). Werry also investigated valeric acid as an end‐capping
agent and claimed the valeric acid delayed gelation even though it was not soluble in the
15

glycerol/fumaric acid solution. It should be noted that glycerol in Werry’s system can be considered a
CB2 monomer since the secondary alcohol is more sterically hindered than the primary alcohols. This
results in different reactivities. Therefore, the monomer is composed of two equivalent B functional
groups and one C functional group. The research herein involves evaluation of varying the A2:CB2
monomer ratio and adding a third monomer (polyethylene glycol monomethyl ether or acid terminated
polyethylene glycol) as a means to control gelation (see Scheme 8 and Scheme 9). The polyethylene
glycol methyl ether (PEG) molecular weight was also varied to examine the effect of size on end‐capping
effectiveness. The PEG and acid terminated polyethylene glycol serve as end‐capping agents which will
prohibit intramolecular covalent bonding of the terminal monomer. These agents were chosen because
they are considered GRAS and are frequently used in the pharmaceutical industry. Additionally, they are
water soluble which can be advantageous in biological systems.
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Scheme 8: A2 + CB2 polymerization.
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Scheme 9: PEG end‐capping.
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According to Werry, the fumaric acid entity in the hyperbranched polymer contains an alkene
which provides a nucleophilic site.30 However, it should be noted that the alkene is in conjugation and is
therefore only a weak nucleophile at best. In this project, two active pharmaceutical ingredients (APIs),
Acetaminophen and Ondansetron, were added to the hyperbranched polymer to evaluate drug delivery
possibilities.
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Figure 12: Acetaminophen and Ondansetron.
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II.

EXPERIMENTAL

All 1H and 13C NMR spectra were generated using a Bruker AVANCE 300 MHz NMR operating at
300 and 75.5 MHz, respectively. Samples were dissolved in deuterated dimethyl sulfoxide (DMSO‐d6)
obtained from Sigma‐Aldrich. Gel Permeation Chromatography (GPC) data were obtained using a
Viscotek Model 300 TDA GPC with refractive index, viscosity and light scattering detectors and two
Polymer Laboratories 5 µm PLGel Mixed C columns. The columns were maintained at 40°C and mobile
phase containing N‐methylpyrrolidone (0.5% LiBr) was pumped at 0.80 mL/min using a
Thermoseparation Model P1000 HPLC pump. GPC analyses were also performed using a Viscotek GPC
with a 270 Dual (viscosity and light scattering) Detector, a VE3580 RI detector and two Agilent PLGel
HPLC columns. The columns were maintained at 40°C and mobile phase containing dimethylformamide
(0.5% LiBr) was pumped at 0.80 mL/min using a PerkinElmer 200 HPLC pump. A VanKel VK7000
dissolution apparatus with a VK8000 autosampler was used for dissolution studies. The dissolutions
were conducted using USP apparatus 2 (paddle) at 50 rpm. A Hitachi HPLC 7000 High Performance
Liquid Chromatograph (HPLC) with UV/Vis detection (216 nm) was employed for assay and impurity
analyses. The separation was performed using a Zorbax SB‐CN column (250 x 4.6 mm, 5 µm particle
size) from Agilent with a mobile phase (0.02M Phosphate buffer (pH 2.0):CH3CN, 80:20, v:v) flow rate of
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1.5 mL/min. Differential Scanning Calorimetry (DSC) data were obtained on TA Instruments DSC Q200
from ‐60°C to 200°C at 10°C/min.
All reagents were used as received. Fumaric acid, glycerol, p‐toluenesulfonic acid (p‐TSA) and t‐
butyl chloroacetate were procured from Sigma‐Aldrich. Poly (ethylene glycol) monomethyl ether (PEG)
Mn750 and Mn2000 were also received from Sigma‐Aldrich. PEG Mn 350 was received from Sigma.
Potassium t‐butoxide was obtained from Fluka and t‐butyl chloroacetate (t‐BCA) was purchased from
Sigma‐Aldrich. Chloroform, isopropyl alcohol (IPA) and ethyl ether were received from BDH, EMD and
Fisher, respectively. Methanol and Karl Fischer Reagent were received from EMD.
A.

Synthesis of AcidTerminated PEG
Following a literature procedure,31 PEG (Mn 2000) was modified to contain a terminal acid group.

Approximately 5 g PEG Mn2000 (2.2 mM) was added to a 250‐mL round bottom flask. Toluene (~ 100
mL) was added and the vessel was fitted with a Dean‐Stark trap and a condenser with N2 flow. The flask
was heated at 150°C for 1 hour and then cooled to room temperature. Potassium t‐butoxide (0.6 g) was
added and the mixture was stirred for 1.5 hours at room temperature. An aliquot (2.2 g) t‐butyl
chloroacetate (end‐capping agent) was added and the reaction was stirred for an additional hour at
room temperature. The solvent was removed under vacuum at 100°C. The precipitate was re‐
precipitated using chloroform, IPA and ether to obtain an acid‐terminated PEG (see Figure 13).
Figure 13: Acid‐terminated PEG.
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O
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B.

A2 + CB2 Polymerization (1:1 Ratio)
The A2 + CB2 polymerizations with A2:CB2 at a 1:1 molar ratio were typically performed by adding

fumaric acid (5 g) and glycerol (4 g) to a 100‐mL three neck round bottom flask equipped with a gas inlet
and outlet. The mixture was heated (either 140°C or 150°) while stirring under N2 until the fumaric acid
dissolved. An aliquot of p‐TSA (~20‐25 mg) was then added. The reaction was allowed to proceed until
the gelation point was almost reached (i.e. the stir bar stopped stirring). The resulting polymer was a
clear, viscous gel‐like material. Since the polymer was prepared in the melt in a single vessel, the
reaction yield was not determined and was assumed 100%.
C.

A2 + CB2 Polymerization (1:1 Ratio) with AcidTerminated PEG
Fumaric acid (5 g), glycerol (4 g) and Acid‐Terminated PEG (1 g) were added to a 100‐mL three

neck round bottom flask and heated to 145°C while stirring under N2. After the fumaric acid dissolved,
p‐TSA (~27 mg) was added and the reaction was allowed to proceed for 2.5 hours until near the gelation
point. The polymer was clear and highly viscous. Once again, overall yield was not determined.
D.

A2 + CB2 Polymerization with PEG EndCapping (1:1:0.1 Ratio)
In general, the polymerizations with PEG end‐capping at a A2:CB2:PEG molar ratio of 1:1:0.1 were

performed by combining fumaric acid (5 g), glycerol (4 g) and PEG Mn350 (3 g) in a 100‐mL three neck
round bottom flask. The mixture was heated at 150°C under N2 while stirring until the fumaric acid
dissolved. The p‐TSA catalyst (~20‐25 mg) was added and the reaction was allowed to continue until
near gelation. The final product was a clear, viscous gel.
E.

A2 + CB2 Polymerization with PEG EndCapping (1:1.3:0.2Ratio)
Typically, the reactions with A2:CB2:PEG at 1:1.3:0.2 molar ratio were performed by adding

fumaric acid (4 g), glycerol (4 g) and PEG Mn350 (3 g) to a 100‐mL three neck round bottom flask. The
combination was stirred under N2 at 150°C until the fumaric acid dissolved. An aliquot (~20‐25 mg) p‐
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TSA was added. The reaction was allowed to continue until the gelation point was almost reached. The
resulting polymer was clear and viscous.
F.

A2 + CB2 Polymerization with PEG EndCapping (1:0.6:0.1 Ratio)
The basic procedure for preparing polymerization with the A2:CB2:PEG at a molar ratio of

1:0.6:0.1 was to combine fumaric acid (5 g), glycerol (3 g) and PEG Mn350 (3 g) in a 100‐mL three neck
round bottom flask. The mixture was stirred under N2 at 150°C. Once the fumaric acid dissolved, p‐TSA
(~20‐25 mg) was added to the vessel. Polymerization was allowed to occur until the reaction was near
gelation and a clear, viscous gel‐like liquid was obtained. 1H NMR (DMSO, δ): 2.50, 3.24, 3.31, 3.51,
3.67, 4.06, 4.19, 4.29, 4.98, 6.63, 6.71, 6.82.
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C NMR (DMSO, δ): 57.96, 62.37, 63.03, 69.04, 69.50,

69.71, 71.20, 72.41.
G.

A2 + CB2 Polymerization with Varied Molecular Weight PEG
Polymers were prepared at an A2:CB2:PEG molar ratio of 1:1:0.2. This was done by adding fumaric

acid (5 g), glycerol (4 g) and PEG (~0.2 – 0.25 moles) of Mn 350, 750 or 2000 to a 100‐ml three neck
round bottom flask. The contents were heated at 150°C while stirring under N2 or argon until the
fumaric acid dissolved. The p‐TSA catalyst (~20‐25 mg) was added and the reaction was allowed to
proceed until near the gelation point. The final products were gel‐like and were clear, opaque and off‐
white to yellow for the polymers prepared with PEG Mn 350, 750 and 2000, respectively. 1H NMR
(DMSO, δ): 2.51, 2.55, 2.73, 2.89, 3.22, 3.49, 3.66, 4.18, 6.70, 6.81, 7.93.

13

C NMR (DMSO, δ): 57.98,

59.30, 59.63, 60.16, 62.31, 62.96, 64.32, 65.77, 65.89, 66.67, 67.96, 69.02, 69.49, 69.70, 71.19, 72.17.
H.

A2 + CB2 Polymerization with CB2 Added in Portions
The A2 + CB2 syntheses containing the various molecular weights of PEG end‐capping agent were

repeated where only approximately half of the CB2 monomer was added initially. After approximately
two hours the remaining glycerol was added. The polymerization was allowed to continue until the
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polymer approached gelation. The polymers resembled those obtained with all the CB2 monomer added
initially. 1H NMR (DMSO, δ): 2.55, 2.73, 2.88, 2.98, 3.22, 3.49, 3.74, 4.03, 4.18, 4.26, 6.63, 6.70, 6.81.

13

C

NMR (DMSO, δ): 57.96, 59.28, 59.62, 60.16, 62.29, 62.94, 64.30, 65.76, 65.89, 66.65, 67.96, 69.01,
69.48, 69.69, 71.18, 72.14, 72.32.

III.
A.

RESULTS AND DISCUSSIONS

Glycerol Water Content
Since glycerol is a liquid at room temperature and the material used in this research was stored in

a plastic bottle with a rubber stopper, water uptake was a possibility. A significant amount of water
could lead to stoichiometric imbalance and affect the degree of polymerization. The water content of
the CB2 monomer was determined in duplicate by Karl Fischer (Mettler DL35) titration. Approximately
0.5 mL glycerol was added to a vessel containing previously rendered anhydrous methanol. The vessel
was titrated with Karl Fischer Reagent after a two‐minute stir time. The average water content of the
glycerol used in these studies was determined to be 0.5% w/w. Since the water content was less than
1% w/w, no correction factor was applied to the glycerol molecular weight before use.
B.

A2 + CB2 Polymerization at a 1:1 Molar Ratio
Two syntheses with fumaric acid and glycerol at approximately a 1:1 molar ratio were performed

at 150°C under N2 on different days. One reaction did not crosslink, or gel, until after about 5 hours
while the other reaction gelled after just 2.5 hours. These observations demonstrated that there is
great difficulty in controlling the onset of gelation in A2 + CB2 reactions in the melt phase. Additionally,
the reaction rate did not appear to be reproducible on a day to day basis. This apparent lack of control
is most likely attributed to variability in the N2 flow rate, the temperature of the reaction vessel and
slight differences in the molar ratios. The effect of changes in molar ratio has been previously discussed
and the potential effect from changes in the temperature of the reaction vessel is obvious: if the
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temperature is erroneously high, the reaction should proceed faster, if it is erroneously low, the reaction
should proceed slower. However, the effect of variability in the nitrogen flow rate may not be as
apparent. One can surmise though that at higher N2 rates, the water from the reaction vessel should be
removed faster. This would push the equilibrium towards the products and therefore increase the
polymerization reaction rate (See Scheme 10).
Scheme 10: Fumaric acid + glycerol polymerization.
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The 1:1 molar ratio polymerization was repeated two more times, but with the temperature
reduced to 145°C. One reaction cross‐linked within an hour while the other reached the gelation point
around an hour and a half.
The polymerization was repeated again, but the temperature was reduced to 140°C and 143°C
(fumaric acid did not fully dissolve at 140°C so the temperature was increased). This time the polymers
gelled around 3.5 and 1.5 hours, respectively. The need for better control of gelation was obvious.
C.

A2 + CB2 with AcidTerminated PEG
The acid‐terminated PEG represented an A2 + CB2 polymerization with excess A functionality.

Although the acid‐terminated PEG was suspected to have a different reactivity than that of fumaric acid,
it was expected that the acid group on the PEG would react with the CB2 monomer to reduce cross‐
linking. The synthesis using this design employed approximately a 0.02 molar equivalent of the acid‐
terminated PEG and was performed at 145°C. The critical point of gelation was reached after
approximately 2.5 hours. It is suspected that not enough PEG was present to prevent cross‐linking. An
aliquot of the sample was dissolved in NMP and analyzed by GPC. A chromatogram is depicted in Figure
14. The weight average molecular weight (Mw) was approximately 7800 Daltons (Da) while the number
average molecular weight (Mn) was about 2700 Da which corresponded to a polydispersity index (PDI) of
2.8. This strategy was aborted at this point because PEG with excess B functionality was readily
available and more cost effective.
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Figure 14: Polymer with acid‐terminated PEG.

D.

A2 + CB2 with PEG
Initial end‐capping studies with polyethylene glycol methyl ether (PEG) involved maintaining a 1:1

ratio of A2 and CB2 monomers in the presence of three different molecular weight PEGs (Mn = 350, 750
and 2000 Da). The amount of PEG added ranged from 0.01 to 0.09 molar ratios in comparison to the
monomers. The syntheses were allowed to proceed until the polymers approached the gelation point
(i.e. when the stir bar could no longer move). The reaction time ranged from 75 minutes to 4.5 hours
and there was no apparent correlation between the PEG amount present and the time to reach gelation.
Nor was there a direct relationship between the size of PEG used and the gelation point. A summary of
the data may be found in Table 1.

Table 1: Gelation summary.
PEG Mn (Da)
350
750
750
2000
2000

Molar Ratio (A2:CB2:PEG)
1:1:0.07
1:1:0.03
1:1:0.09
1:1:0.01
1:1:0.03
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Gelation Time (hours)
2.0
3.0
2.5
1.3
4.5

The molecular weights of the polymers were determined by removing aliquots during the
reaction and analyzing by GPC. The Mw ranged from approximately 5000 to 7700 Da. Representative
chromatograms for PEG Mn 750 at a molar ratio of 0.03 in relation to the monomers are presented in
Figure 15.
Figure 15: GPC overlay (1:1:0.03 A2:CB2:PEG 750).

The ultimate goal of these end‐capping studies was to reproducibly obtain the highest molecular
weight polymers possible while controlling gelation. In addition, the end‐capped polymers should be
economic to prepare and be suitable for formulating finished drug products. Since cross‐linking was not
controlled, further syntheses were conducted using PEG Mn 350 at a molar ratio of 0.2 with respect to
the A2 and CB2 monomers. Synthesis was conducted under the same conditions as used for previous
studies and gelation was delayed until approximately 5 to 8 hours into the reaction. Aliquots were
removed during the reaction and analyzed by GPC for molecular weight determination. The typical Mw
was around 4400 Da while the Mn was approximately 2700 Da which corresponded to a PDI of 1.6. An
overlay of representative GPC chromatograms is depicted in Figure 16.
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Figure 16: GPC overlay for polymer with PEG Mn 350 at a 0.2 molar ratio.

Since the gelation point was extended by increasing the molar ratio of PEG to 0.2, the next goal
of this project was to attempt to improve the granularity of the polymers. This was desirable so the
polymers could be better processed with APIs. Initially PEG Mn 350 was added to the reaction vessel at
a molar ratio of 1:1:0.2 (A2:CB2:PEG). After five hours the polymer was transferred to a
polytetrafluoroethylene (PTFE) sheet and placed into a vacuum oven at approximately 28 inches Hg and
110°C for about 15 hours. The polymer was removed from the PTFE sheet and broken into pieces. At
this point, the polymer was still pliable. The above experiment was repeated at a 1:1.3:0.2 (A2:CB2:PEG)
molar ratio. After five hours the polymer was dried under vacuum at 12 inches Hg and 60°C for one
hour. After one hour the oven was increased to 27 inches Hg and 100°C and the polymer was heated for
another 30 minutes. This second polymer was also somewhat pliable when removed from the PTFE
sheet. However, both of these macromolecules were insoluble in numerous solvents: isopropanol,
acetone, methanol, acetonitrile, diethyl ether, water, NMP and DMF. The first polymer was slightly
soluble in 1,4‐dioxane. It is suspected that additional polymerization occurred in the vacuum oven and
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the polymers became infinitely large. While this physical property may be desirable for some
applications, it is not advantageous for pharmaceuticals.
The next set of syntheses involved adding only half of the CB2 monomer at the beginning of the
synthesis. This was done in an attempt to allow the PEG to react with the A2 monomer to optimize the
end‐capping. In the first reaction, fumaric acid and glycerol were combined with PEG Mn 350 at
1:0.6:0.2 molar ratios and heated at 150°C under nitrogen for two hours. An aliquot was removed and
titrated with 0.01N NaOH to determine how much unreacted A2 monomer was present. It was
determined that approximately 21 meq free acid groups remained around 2 hours into the reaction
which corresponds to approximately 49% of the initial acid groups. An additional 0.5 molar equivalent
of glycerol was added to the reaction vessel and polymerization was allowed to continue for another 2.5
hours. Aliquots were removed and placed in DMF and DMSO‐d6 for GPC and NMR analyses,
respectively. The polymer was readily soluble in DMSO‐d6 but only partially soluble in DMF. The
remaining polymer was transferred to a PTFE sheet and placed at room temperature overnight. The
polymer was then dried in a vacuum at 60°C for four days. The PTFE sheet was removed from the oven
and the polymer film was lifted from the sheet, turned over and returned to the vacuum oven for
another three days. This process produced a flexible non‐tacky polymer but the final product was not
soluble in DMF or DMSO‐d6. It was suspected that cross‐linking occurred during the drying step so the
reaction was repeated and the resulting polymer was dried for only two hours under vacuum at room
temperature. The dried polymer was not soluble in DMF or DMSO‐d6 but it was suspected this was due
to nitrogen and argon issues that were encountered during synthesis (the gas cylinders were turned off
during the reaction) rather than from over drying the polymer.
The approach above was also performed using PEG Mn 750 at a 1:0.6:0.04 A2:CB2:PEG molar
ratio. An additional 0.4 molar equivalents of glycerol was added after one hour. The polymer
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approached the gelation point after another 2 hours so the reaction was stopped. The polymer was
transferred to a PTFE sheet and placed in the vacuum oven at room temperature for 2.5 hours. The
polymer was only marginally soluble in DMF and DMSO‐d6. In order to further investigate the solubility
issues encountered with this polymerization system, two side by side syntheses were performed. One
reaction contained a molar ratio of A2:CB2:PEG Mn 350 at 1:0.6:0.1 while the other was at 1:1:0.1. Both
were heated at 150°C under nitrogen. After one hour, an additional 0.5 molar equivalent CB2 was added
to the vessel containing only 0.6 molar equivalents of glycerol to start. The polymer gelled within 10
minutes and was not usable for further analyses. The polymer at the1:1:0.1 molar ratios was
transferred to a petri dish and dried under vacuum at room temperature for 2 hours. Aliquots of this
polymer were placed in various solvents to evaluate solubility. While the polymer was slightly soluble in
toluene, it was insoluble in DMF, isopropanol, ethyl acetate, acetone, methanol and chloroform.
Gelation was still an issue so the PEG molar equivalent ratio was increased to about 0.3 with
respect to the A2 and CB2 monomers. Six additional reactions were performed using fumaric acid,
glycerol and either PEG Mn 350, PEG Mn 750 or PEG Mn 2000. Half of the syntheses were conducted with
all of the CB2 monomer added at the beginning of the reaction while the other half were performed with
only half the CB2 monomer added initially and the remaining monomer added after 90 to 130 minutes.
The reactions were conducted at 150°C under either nitrogen or argon. The final composition of each
system was at a 1:1:0.3 A2:CB2:PEG molar ratio. Polymerization was allowed to proceed for anywhere
between 6.5 to 10.5 hours. The increase in PEG concentration was expected to prevent cross‐linking by
end‐capping even more of the A2 monomers versus reactions that were conducted using only ≤0.2 molar
equivalents of PEG.

There was no visible difference between the two polymers that were made with the same
molecular weight PEG. However, as expected, there was significant difference in the appearance
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between the polymers prepared with different molecular weight PEG: the polymers containing PEG Mn
2000 resembled lip balm while the polymers with Mn 350 were a viscous liquid. The polymers with PEG
Mn 750 were somewhere in between. Aliquots of each polymer were dissolved in DMF and DMSO‐d6 for
GPC and NMR analyses, respectively.

No significant difference was observed in the GPC data between the two polymers prepared
with PEG Mn 350. The Mw and Mn were approximately 5100 and 2900 Da, respectively, with a PDI of 1.7.
Refer to Figure 17 for an overlay of the chromatograms. A slight difference was observed in the proton
NMR spectra in that the peak at 3.6 ppm in the polymer where all of the CB2 was added at the beginning
of the reaction shifted downfield to about 3.8 ppm in the polymer where only half of the CB2 was added
initially. This is most likely attributed to either residual acetone from cleaning the NMR tube or residual
water in the polymer. The spectra are presented in Figure 18. The 13C DEPT spectra of the two
polymers containing PEG Mn 350 were nearly identical as shown in Figure 19. It should be noted that
the 13C DEPT spectra were similar to those reported by Werry indicating that both linear and dendritic
units are present.30 The dendritic units are formed when each of the three functional groups on the
glycerol undergo condensation with the fumaric acid to form ethers. The linear units are formed when
only two of the functional groups undergo condensation. The degree of branching was estimated from
the intensities of the predicted linear, terminal and dendritic glycerol units in the 13C DEPT spectra. The
estimated DBs obtained were 0.66 and 0.69 for the polymers with ½ the CB2 and all the CB2 added
initially, respectively.

31

Figure 17: GPC overlay of polymers with PEG Mn 350.

Figure 18: Proton spectra of polymers with PEG Mn 350.
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Figure 19: 13C DEPT spectra of polymers with PEG Mn 350.

For the two polymers prepared with PEG Mn 750, there was little difference in the GPC data
(Figure 20): Mw and Mn were approximately 5200 and 3200 Da which corresponds to a 1.6 PDI. The
proton and 13C spectra were nearly superimposable (Figure 21 and Figure 22). It should be noted that
the Mw of these polymers is only approximately 2% more than those prepared with Mn 350 while the Mn
is about 10% higher. The estimated DBs were 0.69 and 0.65 for the polymers with ½ the CB2 and all the
CB2 added initially, respectively.
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Figure 20: GPC overlay of polymers with PEG Mn 750.

Figure 21: Proton spectra of polymers with PEG Mn 750.
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Figure 22: 13C spectra of polymers with PEG Mn 750.

The two polymers prepared with the highest molecular weight PEG (Mn 2000) were also virtually
identical. The Mw and Mn were approximately 8500 and 6700 Da, respectively, which corresponds to a
PDI of 1.3. An overlay of the GPC chromatograms is depicted in Figure 23. The proton NMR spectra
were essentially superimposable as can be seen in Figure 24. The 13C spectra were also very similar.
The estimated DBs were 0.65 and 0.49 for the polymers with ½ the CB2 and all the CB2 added initially,
respectively.
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Figure 23: GPC overlay of polymers with PEG Mn 2000.

Figure 24: Proton spectra of polymers with PEG Mn 2000.
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Figure 25: 13C spectra of polymers with PEG Mn 2000.

As has been discussed, no significant differences were observed between the polymers
prepared with all of the CB2 monomer and only half of the CB2 monomer added initially. As expected,
the polymers prepared with the different molecular weight PEGs were different. A summary of the
molecular weights is provided in Table 2. There was significant difference in the physical appearance
but the 13C DEPT NMR data did not exhibit vast differences as depicted in Figure 27 and Figure 29 for the
polymers where half the CB2 was added initially and where all of the CB2 was added initially, respectively.
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Table 2: Molecular weight summary of polymers with different PEG.
PEG Mn (Da)
350
750
2000

Mw (Da)
5100
5200
8500

Mn (Da)
2900
3200
6700

PDI
1.7
1.6
1.3

Figure 26: Proton spectra of polymers with half CB2 added initially.
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DB
0.66‐0.69
0.65‐0.69
0.49‐0.65

Figure 27: 13C DEPT spectra of polymers with half CB2 added initially.

Figure 28: Proton spectra of polymers with all CB2 added initially.
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Figure 29: 13C DEPT spectra of polymers with all CB2 added initially.

The A2 + CB2 polymer systems were also evaluated by differential scanning calorimetry (DSC). As
anticipated, the two polymers with the same molecular weight PEG had similar thermograms and were
characteristic of the corresponding PEG. For instance, the polymers with PEG Mn 350 had a Tm less than
0°C (~‐40°C) as shown in Figure 30. The polymers with PEG Mn 750 and Mn 2000 had a Tm of 19‐20°C and
46‐47°C, respectively (refer to Figure 31 and Figure 32).
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Figure 30: DSC of polymers with PEG Mn 350.

Figure 31: DSC of polymers with PEG Mn 750.
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Figure 32: DSC of polymers with PEG Mn 2000.

PEG Mn 350 was chosen as the first end‐capping agent for investigation of an A2 + CB2 polymer
system containing API. Acetaminophen (APAP) was selected as the API since it was readily available.
APAP (~1 g) was added to a 1:1:0.3 A2:CB2:PEG molar ratio polymer at the end of the four hour synthesis
to yield a 7% w/w formulation. The formulation turned a golden yellow. An aliquot was dissolved in
DMF and analyzed by GPC. The resulting chromatogram is depicted in Figure 33. The synthesis was
repeated using PEG Mn 750 at a 0.2 molar ratio with respect to the A2 and CB2 monomers. The APAP
was added approximately 2.5 hours after the start of the reaction and the formulation was heated at
150°C for another hour while stirring. This resulted in a 4% w/w APAP formulation which was brown. It
was suspected that the APAP degraded in both reactions since APAP has been demonstrated to degrade
in solution. 32 Therefore, another API was selected.
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Figure 33: Polymer with APAP.

Ondansetron Hydrochloride was the next active pharmaceutical ingredient added to the A2 + CB2
system. Ondansetron was chosen because it was also readily available. Ondansetron Hydrochloride was
added two hours into the synthesis of a 1:1:0.3 A2:CB2:PEG Mn 350 polymer at a 15% w/w ratio. The
reaction was allowed to proceed for another six hours. The resulting formulation was bright orange
which suggests the formulation was highly conjugated. An aliquot was dissolved in DMF for GPC
analysis. The Mw and Mn were approximately 4700 and 2900 Da, respectively, which corresponds to a
PDI of 1.6. Refer to Figure 34 for the GPC chromatogram. The polymer was also analyzed by HPLC with
UV detection at 216 nm. A standard and the sample were diluted in a buffer:acetonitrile (50:50, v:v)
solution to yield approximately 0.15 mg Ondansetron HCl per mL. An aliquot (10 µL) was injected into a
Hitachi 7000 HPLC system with the column temperature maintained at 35°C. The Ondansetron peak in
the sample was quantitated versus that in the standard. The Ondansetron present in the polymer was
4.3% which is equivalent to a loss of 71%. The chromatographic purity based on area percent was 32%.
A representative chromatogram is presented in Figure 35. Dissolution testing was performed on the
polymer to estimate the time frame in which the drug would be released from the polymer in the
gastrointestinal (GI) tract. If Ondansetron was 100% released during the first 60 minutes, the
formulation would be considered an immediate‐release dosage form33. On the other hand, if the drug
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was zero to partially released at 1 hour and then fully released at a later time point, it would be
considered a modified‐release dosage form. The polymer was analyzed in triplicate by adding
approximately 140 mg into a dissolution vessel containing 700 mL 0.1N HCl. After two hours 200 mL pH
6.8 buffer modifier was added. Aliquots were removed at 1, 2, 6, 8, 16 and 20 hours and analyzed by
HPLC. The samples were compared to a standard containing 21 µg Ondansetron HCl per mL. Assuming
a label claim of 4.3% based on the assay above, the polymer released the Ondansetron during the first
hour (103% released) and is considered an immediate‐release dosage form. A representative
chromatogram is depicted in Figure 36.
Figure 34: GPC of polymer with Ondansetron.

Figure 35: Representative assay/impurity chromatogram for polymer with Ondansetron.
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Figure 36: Representative dissolution chromatogram of polymer with Ondansetron.

Due to concern that the efficacy of the API had been compromised, either through degradation
or covalent bonding with the polymer, it was decided to repeat the reaction but to add the Ondansetron
to the polymer at room temperature after synthesis. The theoretical amount of Ondansetron HCl added
was 16% w/w and the final formulation was light tan. Aliquots were dissolved in DMF and DMSO‐d6 for
GPC and NMR analyses, respectively. The GPC chromatogram was similar to that found in Figure 34
above. The NMR spectra are presented in Figure 37 and Figure 38. An aliquot of the polymer was
assayed by HPLC with UV detection and the Ondansetron amount present in the polymer was
determined to be 16% w/w when compared to a standard. This corresponded to 100% of theoretical.
Little degradation was observed in the chromatogram (refer to Figure 39). In order to evaluate release
of Ondansetron from the polymer in the gastrointestinal tract, dissolution testing was performed. The
polymer was analyzed as described above except aliquots were removed from the dissolution vessels at
0.25, 0.5, 1, 1.5, 2, 5 and 20 hours. The Ondansetron was 96% released from the polymer in 15 minutes
and was fully released (101%) within 30 minutes. A representative chromatogram is depicted in Figure
40. This corresponds to an immediate release formulation.
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Figure 37: Proton NMR spectrum of polymer with Ondansetron.

Figure 38: 13C DEPT NMR spectrum of polymer with Ondansetron.
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Figure 39: HPLC chromatogram of final polymer with Ondansetron.

Figure 40: Dissolution chromatogram of final polymer with Ondansetron (30 min).
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IV.

CONCLUSIONS

Numerous A2 + CB2 polymers were made with low levels (≤ 0.09 molar ratio with respect to A2
and CB2) of excess B (PEG) added as an end‐capping agent. Although these polymers ranged in weight
average molecular weights between 5000 and 7700 Da, gelation was difficult to control. As the end‐
capping agent was increased (~0.2 molar ratio with respect to A2 and CB2), gelation was better
controlled, but gelling could be attained if the polymers were dried in a vacuum oven. This resulted in
insoluble cross‐linked polymers. Similar results were obtained when the ratio of A2:CB2 was varied in the
presence of the same end‐capping agent: the vacuum‐dried polymer was poorly soluble. Even as the
molecular weight of the end‐capping agent was increased, the polymers would undergo gelation in the
vacuum oven.
When the excess B end‐capping agent was increased further (~0.3 molar ratio with respect to A2
and CB2) and its molecular weight varied, gelation was better controlled. The resulting A2 + CB2 system
polymers ranged in weight average molecular weights from ~5100 to ~8500 Da. The hyperbranched
polymers exhibited physical properties similar to the PEG end‐capping agents from which they were
derived. When the biocompatible, end‐capped polymer was combined with Ondansetron HCl, it
appeared to be a viable immediate‐release formulation.
Future work includes conducting a model study of the end‐capped system similar to that
performed by Werry to confirm the degree of branching.30 Replacement of the p‐TSA catalyst with GRAS
compounds such as HCl or CH3COOH is desired. APIs which have a preferred immediate‐release need
such as sleep aids (i.e. Diphenylhydramine) should be evaluated with the existing A2 + CB2 end‐capped
system. Additionally, attachment of Ondansetron HCl to the polymer should be developed in order to
achieve modified‐release formulations.
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